IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability.
IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability.
复制标题
DOI:
10.1371/journal.pone.0042088
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Stohlman SA
中科院分区:
文献类型:
--
作者:
Hindinger C;Bergmann CC;Hinton DR;Phares TW;Parra GI;Hussain S;Savarin C;Atkinson RD;Stohlman SA
Demyelination and axonal degeneration are determinants of progressive neurological disability in patients with multiple sclerosis (MS). Cells resident within the central nervous system (CNS) are active participants in development, progression and subsequent control of autoimmune disease; however, their individual contributions are not well understood. Astrocytes, the most abundant CNS cell type, are highly sensitive to environmental cues and are implicated in both detrimental and protective outcomes during autoimmune demyelination. Experimental autoimmune encephalomyelitis (EAE) was induced in transgenic mice expressing signaling defective dominant-negative interferon gamma (IFN-γ) receptors on astrocytes to determine the influence of inflammation on astrocyte activity. Inhibition of IFN-γ signaling to astrocytes did not influence disease incidence, onset, initial progression of symptoms, blood brain barrier (BBB) integrity or the composition of the acute CNS inflammatory response. Nevertheless, increased demyelination at peak acute disease in the absence of IFN-γ signaling to astrocytes correlated with sustained clinical symptoms. Following peak disease, diminished clinical remission, increased mortality and sustained astrocyte activation within the gray matter demonstrate a critical role of IFN-γ signaling to astrocytes in neuroprotection. Diminished disease remission was associated with escalating demyelination, axonal degeneration and sustained inflammation. The CNS infiltrating leukocyte composition was not altered; however, decreased IL-10 and IL-27 correlated with sustained disease. These data indicate that astrocytes play a critical role in limiting CNS autoimmune disease dependent upon a neuroprotective signaling pathway mediated by engagement of IFN-γ receptors.
登录
查看更多内容
影响因子:
32.4
作者:
Kang Z;Altuntas CZ;Gulen MF;Liu C;Giltiay N;Qin H;Liu L;Qian W;Ransohoff RM;Bergmann C;Stohlman S;Tuohy VK;Li X
通讯作者:
Li X
影响因子:
3.5
作者:
BECK, J;RONDOT, P;WIETZERBIN, J
通讯作者:
WIETZERBIN, J
影响因子:
4.4
作者:
Fitzgerald, Denise C.;Ciric, Bogoljub;Rostami, Abdolmohamad
通讯作者:
Rostami, Abdolmohamad
DOI:
10.4049/jimmunol.0802954
发表时间:
2009-03-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Brambilla R;Persaud T;Hu X;Karmally S;Shestopalov VI;Dvoriantchikova G;Ivanov D;Nathanson L;Barnum SR;Bethea JR
通讯作者:
Bethea JR
影响因子:
6.2
作者:
Hamo, Ludwig;Stohlman, Stephen A.;Bergmann, Cornelia C.
通讯作者:
Bergmann, Cornelia C.